NCT00003759
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT00021099
- Conditions
- Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
NCT00032188
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT00003167
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00706706
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Guangzhou, Guangdong, China
- Pfizer Investigational Site Wuhan, Hubei, China
- Pfizer Investigational Site Nanjing, Jiangsu, China
- Pfizer Investigational Site Beijing, China
NCT00008359
- Conditions
- Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00096525
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00030498
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
NCT00006486
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
NCT00410124
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Novartis Investigative Site Fayetteville, Arkansas, United States
- Novartis Investigative Site Duarte, California, United States
- Novartis Investigative Site Sacramento, California, United States
- Novartis Investigative Site San Francisco, California, United States